Contents
Current Pharmaceutical Design, Volume 12 - Number 8
From the Design to the Clinical Application of Thromboxane Modulators
, 12(8): 903 - 923Jean-Michel Dogne, Julien Hanson, Xavier de Leval, Domenico Pratico, Cecil R. Pace-Asciak, Pierre Drion, Bernard Pirotte and Ke-He Ruan
DOI: 10.2174/138161206776055921
Implications of the Molecular Basis of Prostacyclin Biosynthesis and Signaling in Pharmaceutical Designs
, 12(8): 925 - 941Ke-He Ruan and Jean-Michel Dogne
DOI: 10.2174/138161206776055994
Prostaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer
, 12(8): 943 - 954Makoto Murakami and Ichiro Kudo
DOI: 10.2174/138161206776055912
NAD+-Linked 15-Hydroxyprostaglandin Dehydrogenase: Structure and Biological Functions
, 12(8): 955 - 962H- H. Tai, H. Cho, M. Tong and Y. Ding
DOI: 10.2174/138161206776055958
Hepoxilin Analogs, Potential New Therapeutics in Disease
, 12(8): 963 - 969C. R. Pace-Asciak, X. Li, N. Qiao, D. Reynaud, P. Demin and M. Abdelhaleem
DOI: 10.2174/138161206776055903
Coxibs and Cardiovascular Side-Effects: From Light to Shadow
, 12(8): 971 - 975Jean-Michel Dogne, Julien Hanson, Claudiu Supuran and Domenico Pratico
DOI: 10.2174/138161206776055949
The Role of Unbound Drug in Pharmacokinetics/Pharmacodynamics and in Therapy
, 12(8): 977 - 987Rosario Calvo, John C. Lukas, Monica Rodriguez, Nerea Leal and Elena Suarez
DOI: 10.2174/138161206776055967
Biologicals Dramatic Advances in the Treatment of Psoriasis
, 12(8): 989 - 999Dagmar Wilsmann-Theis, Saskia Martin, Michael Reber, Bartlomiej Kwiek, Thomas Bieber and Natalija Novak
DOI: 10.2174/138161206776055930
Role of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities
, 12(8): 1001 - 1012M. Guido, D. Romualdi and A. Lanzone
DOI: 10.2174/138161206776055895
Webmaster Contact: info@benthamscience.org